VitaDAO Launches Matrix Biosciences to Pursue Life Extension Research
VitaDAO, a decentralized autonomous organization (DAO) focused on funding early-stage longevity research, has announced the launch of Matrix Biosciences. In partnership with biologist Vera Gorbunova, Matrix Biosciences aims to pursue cutting-edge science in treating cancer and age-related diseases. Gorbunova, a professor at the University of Rochester, is renowned for her work in identifying cancer-resistant traits in naked mole-rats.
The idea behind Matrix Biosciences is to bridge the gap between DAO-based research and real-world applications. Unlike VitaDAO, which operates in a decentralized manner, Matrix Biosciences will function as a centralized biotech company. VitaDAO will be the majority shareholder and receive quarterly reports from the newly created company.
VitaDAO and Matrix Biosciences are actively working with regulators to ensure compliance with legal requirements in the healthcare industry. The mission of Matrix Biosciences is to leverage the unique characteristics of naked mole-rats, such as their abundance of high molecular weight hyaluronic acid (HMW-HA), to develop cancer treatments and address age-related diseases in humans.
The Next Blockbuster Therapeutic: Matrix Biosciences’ Research Focus
Matrix Biosciences will focus on researching the anti-cancerous, anti-pain, and pro-longevity properties of HMW-HA found in naked mole-rats. This aligns with VitaDAO’s mission of funding moonshot bleeding-edge research that may not qualify for traditional venture capital or government funding. Driven by its IP-NFT fractionalization model, VitaDAO will initially provide $300,000 in funding for Matrix Biosciences.
Lead scientist Vera Gorbunova, co-director of the University of Rochester’s Aging Research Center, brings her expertise in longevity mechanisms and genome stability to Matrix Biosciences. The launch of Matrix Biosciences signifies VitaDAO’s commitment to advancing biotech research and its determination to establish credibility within the industry.
Hot Take: VitaDAO’s Push for Life Extension Research
VitaDAO’s launch of Matrix Biosciences marks a significant step in the pursuit of life extension research. By establishing a centralized biotech company, VitaDAO aims to bridge the gap between blockchain technology and the biotech industry. The focus on naked mole-rat research and leveraging their unique biological properties highlights VitaDAO’s dedication to funding groundbreaking therapies for cancer and age-related diseases.
Sources:
By
By
By
By
By